Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples